GENETIC COUNSELLING IN SPORADIC CASES OF CONGENITAL CATARACT

2009 ◽  
Vol 49 (4) ◽  
pp. 572-576 ◽  
Author(s):  
S. JENSEN ◽  
E. GOLDSCHMIDT
2020 ◽  
Vol 1 ◽  
pp. 263300402093806
Author(s):  
Suzannah J. Bell ◽  
Ngozi Oluonye ◽  
Philippa Harding ◽  
Mariya Moosajee

Worldwide 20,000–40,000 children with congenital or childhood cataract are born every year with varying degrees and patterns of lens opacification with a broad aetiology. In most cases of bilateral cataract, a causative genetic mutation can be identified, with autosomal dominant inheritance being most common in 44% of cases. Variants in genes involve lens-specific proteins or those that regulate eye development, thus giving rise to other associated ocular abnormalities. Approximately 15% of cases have systemic features, hence paediatric input is essential to minimise comorbidities and support overall development of children at high risk of visual impairment. In some metabolic conditions, congenital cataract may be the presenting sign, and therefore prompt diagnosis is important where there is an available treatment. Multidisciplinary management of children is essential, including ophthalmic surgeons, orthoptists, paediatricians, geneticists and genetic counsellors, and should extend beyond the medical team to include school and local paediatric visual support services. Early surgery and close follow up in ophthalmology is important to optimise visual potential and prevent amblyopia. Routine genetic testing is essential for the complete clinical management of patients, with next-generation sequencing of 115 genes shown to expedite molecular diagnosis, streamline care pathways and inform genetic counselling and reproductive options for the future. Lay abstract Childhood cataract: how to manage patients Cataract is a clouding of the lens in the eye. Cataract occurring in children has many different causes, which may include infections passed from mother to child during pregnancy, trauma, medications and exposure to radiation. In most cases of cataract occurring in both eyes, a genetic cause can be found which may be inherited from parents or occur sporadically in the developing baby itself while in the womb. Cataracts may occur on their own, with other eye conditions or be present with other disorders in the body as part of a syndrome. Genetic testing is important for all children with cataract as it can provide valuable information about cause, inheritance and risk to further children and signpost any other features of the disease in the rest of the body, permitting the assembly of the correct multidisciplinary care team. Genetic testing currently involves screening for mutations in 115 genes already known to cause cataract and has been shown to expedite diagnosis and help better manage children. Genetic counselling services can support families in understanding their diagnosis and inform future family planning. In order to optimise vision, early surgery for cataract in children is important. This is because the brain is still developing and an unobstructed pathway for light to reach the back of the eye is required for normal visual development. Any obstruction (such as cataract) if left untreated may lead to permanent sight impairment or blindness, even if it is removed later. A multidisciplinary team involved in the care of a child with cataract should include ophthalmic surgeons, orthoptists, paediatricians, geneticists and genetic counsellors, and should extend beyond the medical team to include school and local child visual support services. They will help to diagnose and manage systemic conditions, optimise vision potential and help patients and their families access best supportive care.


Author(s):  
Dulce Lima Cunha ◽  
Nicholas Owen ◽  
Vijay Tailor ◽  
Marta Corton ◽  
Maria Theodorou ◽  
...  

Abstract PAX6 is considered the master regulator of eye development, the majority of variants affecting this gene cause the pan-ocular developmental eye disorder aniridia. Although no genotype-phenotype correlations are clearly established, missense variants affecting the DNA-binding paired domain of PAX6 are usually associated with non-aniridia phenotypes like microphthalmia, coloboma or isolated foveal hypoplasia. In this study, we report two missense heterozygous variants in the paired domain of PAX6 resulting in isolated foveal hypoplasia with nystagmus in two independent families: c.112 C > G; p.(Arg38Gly) and c.214 G > C; p.(Gly72Arg) in exons 5 and 6, respectively. Furthermore, we provide evidence that paternal postzygotic mosaicism is the cause of inheritance, with clinically unaffected fathers and reduced affected allele fraction. This work contributes to increase the phenotypic spectrum caused by PAX6 variants, and to our knowledge, is the first report to describe the presence of postzygotic parental mosaicism causing isolated foveal hypoplasia with nystagmus. These results support the growing evidence that suggest an overestimation of sporadic cases with PAX6 variants, which has strong implications for both genetic counselling and family planning.


2020 ◽  
Author(s):  
Fan Fan ◽  
Yi Luo ◽  
Jihong Wu ◽  
Chao Gao ◽  
Xin Liu ◽  
...  

Abstract Purpose Congenital cataract (CC) is a significant cause of lifelong visual loss. Its genetic diagnosis is challenging due to marked genetic heterogeneity. The purpose of this article is to report the genetic findings in sporadic and familial CC patients.Methods Patients (n=54) who were clinically diagnosed with CC and their parents were recruited. Blood samples were collected in our hospital. Mutations were detected by high-throughput, next-generation DNA sequencing (NGS) targeting 792 genes frequently involved in common inherited eye diseases.Results We identified variants in 11/38 cases (28.95%) of sporadic CC and 14/16 cases (87.5%) of familial CC, indicating a significant difference (P=0.000). Of the 14 variants identified in sporadic cases, 9 were previously reported mutations, and 5 were novel mutations, including 2 de novo mutations (CRYBB2 c.487C>T, FYCO1c.215A>T). The most frequent variants in our cohort were in crystallins and cytoskeletal genes (7/30, 23.33%), followed by X-linked syndromic proteins (13.33%) and transcriptional factors (10.00%). Additional information on the possibility of complications with inherited ocular or systemic diseases other than CC was provided in 20/30 (66.67%) variants.Conclusions These results contribute to expanding the mutation spectrum and frequency. Targeted NGS in CC provided significant diagnostic information and enabled more accurate genetic counseling. This study reports the different distributions of mutation genes in familial and sporadic CC cases.


2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 11537-11537 ◽  
Author(s):  
Margherita Nannini ◽  
Milena Urbini ◽  
Valentina Indio ◽  
Angela Schipani ◽  
Bruno Vincenzi ◽  
...  

11537 Background: SDH- deficient GIST, as defined by the loss of expression of SDHB, account up to about 10% of all gastric GIST and generally affect younger population. Germline mutations in SDHB, SDHC, and SDHD occur in about 20–30% of SDH- deficient, that may be referred to a hereditary condition known as hereditary GIST-paraganglioma syndrome (Carney-Stratakis Syndrome), whereas germline SDHA mutations have been rarely described in apparently sporadic cases. Currently, even germline testing is recommended for SDH- deficient GIST, there are no clear guidelines for genetic counselling and follow-up of SDH x mutation carriers and relatives, especially for SDHA mutant GIST not yet linked to well-defined hereditary syndrome. The aim of this work was to study the SDHA gene in the normal DNA of patients with SDHA mutant GIST. Methods: Thirteen patients carrying SDHA-mutant GIST were studied (8F/5M). Median age of diagnosis was 45,9 years (range 25-74). All GIST were located in the stomach and 3 patients out 13 presented a metastatic disease. In all cases except one, the GIST was the only cancer presentation and no personal or familial history of cancer was revealed. All cases were negative for SDHB immunohistochemistry. Germline mutations were identified through Sanger sequencing of SDHA in the normal counterpart. Results: Germline mutations were identified in all patients for which normal counterpart was available: 4 cases harboured truncating mutations (S384X, R31X and W119X); 5 cases carried pathogenic missense mutations (G233V, R171H, R589Q, G257A and R600Q) and 2 cases had splice site alterations (c.457-3_457-1 delCAG and c.456+9 C > T). In 8 cases the tumor DNA showed the loss of the corresponding wild-type allele, while in the other 3 cases compound heterozygosity for an additional somatic mutation was detected (R589W, R451C,and R171C). In 2 patients, unfortunately, normal DNA was not available, however both tumours carried two mutational hits on SDHA (one with heterozygous G419R and E564K, and one with homozygous R585Q). Of note, 5 patients presented un-usaul SDHA related clinical characteristics as were not young adult ( > 50 years-old) or no multifocal GIST. Conclusions: We demonstrated that germline SDHA mutations are highly frequent in SDHA- deficient GIST. Therefore, although a clear syndrome has not been defined, genetic counselling and follow-up of SDHA mutation carriers and relatives should be clarified.


1976 ◽  
Vol 112 (9) ◽  
pp. 1284-1285 ◽  
Author(s):  
G. B. Gewirtzman

Author(s):  
Christine Evans ◽  
Peter Harper
Keyword(s):  

2006 ◽  
Vol 37 (S 1) ◽  
Author(s):  
R Biancheri ◽  
F Zara ◽  
A Rossi ◽  
C Bruno ◽  
L Bordo ◽  
...  

1982 ◽  
Author(s):  
Vladimir Marik ◽  
Zdenek Zdrahal ◽  
Eva Seemanova ◽  
Tatana Marikova

Sign in / Sign up

Export Citation Format

Share Document